Brief: Wockhardt says USFDA Accepts Co's NDA For Antibiotic Zaynich
01/12/2025 06:35
Dec 1 (Reuters) - Wockhardt Ltd WCKH.NS: WOCKHARDT LTD - FDA ACCEPTS WOCKHARDT'S NDA FOR ANTIBIOTIC ZAYNICH Source text: ID:nBSE5DHVrk Further company coverage: WCKH.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter